NCT00168090

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrand's Disease.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (planned)
• Sponsor: CSL Behring · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test the safety and effectiveness of Humate-P® to prevent bleeding in patients with von Willebrand Disease who are undergoing surgery.

Conditions

• Von Willebrand Disease
• Blood Coagulation Disorders
• Blood Platelet Disorders
• Hematologic Disease

Interventions

Type	Name	Description
DRUG	Blood coagulation Factor VIII and vWF, human

Timeline

• Start date: 2001-10-01
• Completion: 2006-05-01
• First posted: 2005-09-14
• Last updated: 2011-02-11

Locations

1 site across 1 country: United States